Systems And Methods For Collecting Mononuclear Cells

US2022168485A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022168485-A1
Application numberUS-202217672910-A
CountryUS
Kind codeA1
Filing dateFeb 16, 2022
Priority dateMar 7, 2017
Publication dateJun 2, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Fluid processing assemblies and methods are provided for mononuclear cell collection. Mononuclear cells are separated from red blood cells in a blood separation chamber, with the mononuclear cells and then the red blood cells exiting the chamber via an outlet port. The mononuclear cells and then the red blood cells enter an outlet flow path that is in fluid communication with a mononuclear cell collection container. The outlet flow path includes a visual indicium, which an operator may use to determine the position of the red blood cells within the outlet flow path and when to end mononuclear cell collection by preventing fluid communication between the outlet flow path and the mononuclear cell collection container.

First claim

Opening claim text (preview).

1 - 26 . (canceled) 27 . A fluid processing assembly configured for use in combination with a fluid processing system for separating mononuclear cells from red blood cells, comprising: a blood separation chamber configured to separate mononuclear cells from red blood cells and including an outlet port configured to accommodate the flow of mononuclear cells and then red blood cells exiting the blood separation chamber; a mononuclear cell collection container; and an outlet flow path extending between the outlet port and the mononuclear cell collection container, wherein the outlet flow path includes a visual indicium upstream of the mononuclear cell collection container positioned to indicate that fluid communication between the outlet flow path and the mononuclear cell collection container is to be prevented upon red blood cells flowing through the outlet flow path reaching a location identified by the visual indicium. 28 . The fluid processing assembly of claim 27 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the upstream flexible tubing. 29 . The fluid processing assembly of claim 27 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the cassette. 30 . The fluid processing assembly of claim 27 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the downstream flexible tubing. 31 . A method for collecting mononuclear cells, comprising: separating mononuclear cells from red blood cells in a blood separation chamber; flowing at least a portion of said mononuclear cells out of the blood separation chamber via an outlet port, through an outlet flow path in fluid communication with the outlet port, and into a mononuclear cell collection container; flowing at least a portion of said red blood cells out of the blood separation chamber via the outlet port and into the outlet flow path; and preventing fluid communication between the outlet flow path and the mononuclear cell collection container when said at least a portion of said red blood cells flowing through the outlet flow path reaches a location identified by a visual indicium associated with the outlet flow path. 32 . The method of claim 31 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the upstream flexible tubing. 33 . The method of claim 31 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the cassette. 34 . The method of claim 31 , wherein the outlet flow path is defined by a rigid cassette, an upstream flexible tubing extending between the outlet port and the cassette, and a downstream flexible tubing extending between the cassette and the mononuclear cell collection container, with the visual indicium identifying a location within the downstream flexible tubing. 35 - 47 . (canceled) 48 . The method of claim 31 , wherein said separating mononuclear cells from red blood cells in the blood separation chamber includes separating a plasma constituent from the mononuclear cells and the red blood cells in the blood separation chamber, and further comprising: flowing at least a portion of said plasma constituent out of the blood separation chamber at a current plasma flow rate, calculating an ideal plasma flow rate for said at least a portion of the plasma constituent flowing out of the blood separation chamber, comparing the ideal plasma flow rate to the current plasma flow rate for said at least a portion of the plasma constituent flowing out of the blood separation chamber, determining that said at least a portion of the plasma constituent has decreased clarity when the percent difference between the ideal plasma flow rate and the current plasma flow rate is greater than a threshold value, and determining that said at least a portion of the plasma constituent does not have decreased clarity when the percent difference between the ideal plasma flow rate and the current plasma flow rate is less than the threshold value. 49 . The method of claim 48 , wherein the threshold value is in a range of approximately 25% to approximately 30%. 50 . The method of claim 48 , wherein the threshold value is approximately 20%. 51 . The method of claim 48 , further comprising, upon determining that the plasma constituent has decreased clarity, automatically increasing the current plasma flow rate. 52 . The method of claim 48 , further comprising, upon determining that the plasma constituent has decreased clarity, enabling an operator to selectively increase the current plasma flow rate. 53 . The method of claim 50 , wherein said enabling the operator to selectively increase the current plasma flow rate includes limiting the amount that the operator may increase the current plasma flow rate. 54 . The method of claim 31 , wherein the outlet flow path includes a flexible tubing, and further comprising reversing the direction of flow of said at least a portion of said red blood cells through the flexible tubing to minimize the amount of red blood cells reaching the mononuclear cell collection container. 55 . The method of claim 54 , wherein said reversing the direction of flow of said at least a portion of said red blood cells through the flexible tubing includes automatically initiating the reversal of the direction of flow. 56 . The method of claim 54 , wherein said reversing the direction of flow of said at least a portion of said red blood cells through the flexible tubing includes manually commanding a system controller of a fluid processing system to execute the reversal of the direction of flow. 57 . The method of claim 31 , wherein said separating mononuclear cells from red blood cells in the blood separation chamber includes separating a plasma constituent from the mononuclear cells and the red blood cells in the blood separation chamber, and further comprising: flowing at least a portion of said plasma constituent out of the blood separation chamber, determining whether the plasma constituent has decreased clarity, flowing at least a portion of said mononuclear cells out of the blood separation chamber and into the mononuclear cell collection container, and irradiating said at least a portion of said mononuclear cells in the mononuclear cell collection container with a dosage of light equal to a default dosage when the plasma constituent

Assignees

Inventors

Classifications

  • Sorting or classification of particles or molecules · CPC title

  • Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging · CPC title

  • using separation based on different densities of components, e.g. centrifuging · CPC title

  • by separating the blood components (G01N15/05 takes precedence) · CPC title

  • by irradiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022168485A1 cover?
Fluid processing assemblies and methods are provided for mononuclear cell collection. Mononuclear cells are separated from red blood cells in a blood separation chamber, with the mononuclear cells and then the red blood cells exiting the chamber via an outlet port. The mononuclear cells and then the red blood cells enter an outlet flow path that is in fluid communication with a mononuclear cell…
Who is the assignee on this patent?
Fenwal Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/3496. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).